Concept of autoimmunity following spinal cord injury: Possible roles for T lymphocytes in the traumatized central nervous system

Journal of Neuroscience Research

Volumn 45, Issue 4, 1996, Pages 349-363

  Popovich, P G ^a   Stokes, B T ^a   Whitacre, C C ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

CNS trauma; demyelination; EAE; microglia; neuroimmunology

Indexed keywords

MYELIN BASIC PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; BLOOD BRAIN BARRIER; CELL INFILTRATION; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DEMYELINATION; HISTOPATHOLOGY; IMMUNOREGULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROGLIA; NEUROIMMUNOLOGY; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD INJURY; T LYMPHOCYTE; TISSUE INJURY;

ANIMALS; AUTOIMMUNITY; SPINAL CORD INJURIES; T-LYMPHOCYTES; WOUNDS AND INJURIES;

EID: 0029739941     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19960815)45:4<349::AID-JNR4>3.0.CO;2-9     Document Type: Article

References (107)

1. Aihara N, Tanno H, Hall JJ, Pitts LH, Noble LJ (1994): Immunocytochemical localization of immunoglobulins in the rat brain: Relationship to the blood-brain barrier. J Comp Neurol 342:481-496.
2. Anderson TE, Stokes BT (1992): Experimental models for spinal cord injury research: Physical and physiological considerations. J Neurotrauma (Suppl 9) 1:S135-S142.
3. Appel SH, Smith RG, Alexianu M, Engelhardt J, Mosier D, Colom L, Stefani E (1994a): Neurodegenerative disease: Autoimmunity involving calcium channels. Ann NY Acad Sci 747:183-194.
4. Appel SH, Smith RG, Engelhardt JI, Stefani E (1994b): Evidence for autoimmunity in amyotrophic lateral sclerosis. J Neurol Sci (Suppl) 124:14-19.
5. Banik NL (1992): Pathogenesis of myelin breakdown in demyelinating diseases: Role of proteolytic enzymes. Crit Rev Neurobiol 6:257-271.
6. Behrmann DL, Bresnahan JC, Beattie MS, Shah BR (1992): Spinal cord injury produced by consistent displacement of the cord in rats: Behavioral and histologic analysis. J Neurotrauma 9(3):197-217.
7. Berman JW, Guida MP, Warren J, Amat J, Brosnan CF (1996): Localization of monocyte chemoattractant peptide-1 expression in the central nervous system in experimental autoimmune encephalomyelitis and trauma in the rat. J Immunol 156:3017-3023.
8. Berry M, Riches AC (1974): An immunological approach to regeneration in the central nervous system. Br Med Bull 30(2):135-140.
9. Blight AR (1985): Delayed demyelination and macrophage invasion: A candidate for secondary cell damage in spinal cord injury. CNS Trauma 2:299-315.
10. Blight AR (1992): Macrophages and inflammatory damage in spinal cord injury. J Neurotrauma (Suppl 9) 1:S83-S91.
11. Blight AR (1994): Effects of silica on the outcome from experimental spinal cord injury: Implication of macrophages in secondary tissue damage. Neuroscience 60:263-273.
12. Blight AR, Saito K, Heyes MP (1993): Increased levels of the excitotoxin quinolinic acid in spinal cord following contusion injury. Brain Res 632:314-316.
13. Blight AR, Cohen TI, Saito K, Heyes MP (1995): Quinolinic acid accumulation and functional deficits following experimental spinal cord injury. Brain 118:735-752.
14. Bracken MB, Shepard MJ, Collins WF, Holford TR, Young W, Baskin DS, Eisenberg HM, Flamm E, Leo-Summers L, Maroon J, et al. (1990): A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinalcord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 322:1405-1411.
15. Brierly JB, Field EJ (1948): The connections of the spinal sub-arachnoid space with the lymphatic system. J Anat 82:153-166.
16. Bunge RP, Puckett WR, Becerra JL, et al. (1993): Observations on the pathology of human spinal cord injury: A review and classification of 22 new cases with details from a case of chronic cord compression with extensive focal demyelination. In Seil FJ (ed): "Advances in Neurology, 7th Ed." New York: Raven Press, pp 75-89.
17. Byrnes AP, Rusby JE, Wood MS, Charlton HM (1995): Adenovirus gene transfer causes inflammation in the brain. Neuroscience 66:1015-1024.
18. Cammer W, Bloom BR, Norton WT, Gordon S (1978): Degradation of basic protein in myelin by neutral proteases secreted by stimulated macrophages: A possible mechanism of inflammatory demyelination. Proc Natl Acad Sci USA 75:1554-1558.
19. + T lymphocytes in the central nervous system. Clin Exp Immunol 98:313-318.
20. Claudio L, Kress Y, Factor J, Brosnan CF (1990): Mechanisms of edema formation in experimental autoimmune encephalomyelitis: The contribution of inflammatory cells. Am J Pathol 137:1033-1045.
21. Cross AH, Cannella B, Brosnan CF, Raine CS (1990): Homing to central nervous system vasculature by antigen specific lymphocytes. I. Localization of C14-labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis. Lab Invest 63(2):162-170.
22. Cruse JM, Lewis RE, Bishop GR, Kliesch WF, Gaitan E (1992): Neuroendocrine-immune interactions associated with loss and restoration of immune system function in spinal cord injury and stroke patients. Immunol Res 11:104-116.
23. Cserr HF, Knopf PM (1992): Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: A new view. Immunol Today 13:507-512.
24. Cuzner ML, Hayes CM, Newcombe J, Woodroofe MN (1988): The nature of inflammatory components during demyelination in multiple sclerosis. J Neuroimmunol 20:203-209.
25. David S, Bouchard C, Tsatas O, Giftochristos N (1990): Macrophages can modify the nonpermissive nature of the adult mammalian central nervous system. Neuron 5:463-469.
26. Dijkstra CD, de Groot CJ, Huitinga I (1992): The role of macrophages in demyelination. J Neuroimmunol 40:183-188.
27. Dusart I, Schwab ME (1993): Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord. EurJ Neurosci 6:712-724.
28. Feringa ER, Johnson RD, Wendt JS (1975): Spinal cord regeneration in rats after immunosuppressive treatment. Theoretical considerations and histologic results. Arch Neurol 32:676-683.
29. Flanagan EM, Erickson IB, Viveros Humberto O, Chang SY, Reinhard JF, Jr (1995): Neurotoxin quinolinic acid is selectively elevated in spinal cords of rats with experimental allergic encephalomyelitis. J Neurochem 64:1192-1196.
30. Gehrmann J, Matsumoto Y, Kreutzberg GW (1995): Microglia: Intrinsic immuneffector cell of the brain. Brain Res Rev 20:269-287.
31. Giulian D (1988): Immunosuppression as a treatment for acute injury of the central nervous system. In Reier PJ, Bunge RP, Seil FJ (eds): "Current Issues in Neural Regeneration Research. " New York: Alan R. Liss, pp 281-90.
32. Giulian D, Robertson C (1990): Inhibition of mononuclear phagocytes reduces ischemic injury in the spinal cord. Ann Neurol 27:33-42.
33. Gledhill RF, Harrison BM, McDonald WI (1973): Demyelination and remyelination after acute spinal cord compression. Exp Neurol 38:472-487.
34. Griffin AC, Whitacre CC (1991): Sex and strain differences in the circadian rhythm fluctuation of endocrine and immune function in the rat: Implications for rodent models of autoimmune disease. J Neuroimmunol 35:53-64.
35. Griffiths IR, McCulloch MC (1983): Nerve fibres in spinal cord impact injuries. J Neurol Sci 58:335-349.
36. Griot C, Burge T, Vandevelde M, Peterhans E (1989): Antibody-induced generation of reactive oxygen radicals by brain macrophages in canine distemper encephalitis: A mechanism for bystander demyelination. Acta Neuropathol (Berlin) 78:396-403.
37. Happ MP, Wettstein P, Dietzschold B, Heber-Katz E (1988): Genetic control of the development of experimental allergic encephalomyelitis in rats. Separation of MHC and non-MHC gene effects. J Immunol 141:1489-1494.
38. Harling-Berg CJ, Knopf PM, Cserr HF (1991): Myelin basic protein infused into cerebrospmal fluid suppresses experimental autoimmune encephalomyelitis. J Neuroimmunol 35:45-51.
39. Hayes GM, Woodroofe MN, Cuzner ML (1987): Microglia are the major cell type expressing MHC class II antigen in human white matter. J Neurol Sci 80:25-37.
40. Hirschberg DL, Yoles E, Belkin M, Schwartz M (1994): Inflammation after axonal injury has conflicting consequences for recovery of function: Rescue of spared axons is impaired but regeneration is supported. J Neuroimmunol 50:9-16.
41. Homo-Delarche F, Fitzpatrick F, Christeff N, Nunez EA, Bach JF, Dardenne M (1991): Sex steroids, glucocorticoids, stress and autoimmunity. J Steroid Biochem Mol Biol 40:619-637.
42. Horner PJ, Popovich PG, Reier PJ, Stokes BT (1994): Fetal transplant vascularity: Metabolic and immunologic mechanisms. In Marwah J, Teitelbaum H, Prasad KN (eds): "Neuronal Transplantation: CNS Neuronal Injury, and Regeneration: Recent Advances." Boca Raton, FL: CRC Press Inc, pp 119-140.
43. Howard MC, Miyajima A, Coffman R (1993): T-cell derived cytokines and their receptors. In Paul WE, (eds): "Fundamental Immunology, 3rd Ed." New York: Raven Press, pp 763-800.
44. + T cells: Specificity and function. Immunol Rev 101:39-80.
45. Juhler M, Barry DI, Offner H, Konat G, Klinken L, Paulson OB (1984): Blood-brain and blood-spinal cord barrier permeability during the course of experimental allergic encephalomyelitis in the rat. Brain Res 302:347-355.
46. Kermode AG, Thompson AJ, Tofts P, MacManus DG, Kendall BE, Kingsley, DP, Moseley IF, Rudge P, McDonald WI (1990): Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. Brain 113:1477-1489.
47. Kim JS, Gautam SC, Chopp M, Zaloga C, Jones ML, Ward PA, Welch KM (1995): Expression of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 after focal cerebral ischemia in the rat. J Neuroimmunol 56:127-134.
48. Le WD, Engelhardt J, Xie WJ, Schneider L, Smith RG, Appel SH (1995): Experimental autoimmune nigral damage in guinea pigs. J Neuroimmunol 57:45-53.
49. Lehmann PV, Forsthuber T, Miller A, Sercarz EE (1992): Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 358:155-157.
50. Lehmann PV, Sercarz EE, Forsthuber T, Dayan CM, Gammon G (1993): Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol Today 14:203-208.
51. MacPhee IA, Antoni FA, Mason DW (1989): Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids. J Exp Med 169:431-445.
52. Martin R, McFarland HF (1995): Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit Rev Clin Lab Sci 32:121-182.
53. Mason D, MacPhee I, Antoni F (1990): The role of the neuroendocrine system in determining genetic susceptibility to experimental allergic encephalomyelitis in the rat. Immunology 70:1-5.
54. Matsushima GK, Taniike M, Glimcher LH, Grusby MJ, Frelinger JA, Suzuki K, Ting JP (1994): Absence of MHC class II molecules reduces CNS demyelination, microglial/macrophage infiltration, and twitching in murine globoid cell leukodystrophy. Cell 78:645-656.
55. Matzinger P (1994): Tolerance, danger, and the extended family. Annu Rev Immunol 12:991-1045.
56. Merrill JE, Ignarro LJ, Sherman MP, Melinek J, Lane TE (1993): Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol 151:2132-2141.
57. Miller DJ, Rodriguez M (1995): A monoclonal autoantibody that promotes central nervous system remyelination in a model of multiple sclerosis is a natural autoantibody encoded by germline immunoglobulin genes. J Immunol 154:2460-2469.
58. Miller DJ, Asakura K, Rodriguez M (1995): Experimental strategies to promote central nervous system remyelination in multiple sclerosis: Insights gained from the Theiler's virus model system. J Neurosci Res 41:291-296.
59. Mizrachi Y, Ohry A, Aviel A, Rozin R, Brooks ME, Schwartz M (1983): Systemic humoral factors participating in the course of spinal cord injury. Paraplegia 21:287-293.
60. H2 cells: Different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 7:145-174.
61. Naparstek Y, Cohen IR, Fuks Z, Vlodavsky I (1984): Activated T lymphocytes produce a matrix-degrading heparan sulphate endoglycosidase. Nature 310:241-244.
62. Noble LJ, Wrathall JR (1989): Distribution and time course of protein extravasation in the rat spinal cord after contusive injury. Brain Res 482:57-66.
63. Olsson T, Diener P, Ljungdahl A, Hojeberg B, van der Meide PH, Kristensson K (1992): Facial nerve transection causes expansion of myelin autoreactive T cells in regional lymph nodes and T cell homing to the facial nucleus. Autoimmunity 13:117-126.
64. Olsson T, Sun JB, Solders G, Xiao BG, Hojeberg B, Ekre HP, Link H (1993): Autoreactive T and B cell responses to myelin antigens after diagnostic sural nerve biopsy. J Neurol Sci 117:130-139.
65. Palladini G, Grossi M, Maleci A, Lauro CM, Guidetti B (1987): Immunocomplexes in rat and rabbit spinal cord after injury. Exp Neurol 95:639-651.
66. Paterson PY (1976): Experimental allergic encephalomyelitis: Role of fibrin deposition in immunopathogenesis of inflammation in rats. Fed Proc 35:2428-2434.
67. Paul WE, Seder RA (1994): Lymphocyte responses and cytokines. Cell 76:241-251.
68. Pette M, Fujita K, Kitze B, Whitaker JN, Albert E, Kappos L, Wekerle, H (1990): Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals. Neurology 40:1770-1776.
69. Popovich PG, Reinhard JF, Jr, Flanagan EM, Stokes BT (1994): Elevation of the neurotoxin quinolinic acid occurs following spinal contusion injury. Brain Res 633:348-352.
70. Popovich PG, Horner PJ, Mullin BB, Stokes BT (1996a) A quantitative spatial analysis of the blood-spinal cord barrier I. Permeability changes after experimental spinal contusion injury. Exp Neurol (in press).
71. Popovich PG, Wei P, Stokes BT (1996b): The cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J Comp Neurol, submitted.
72. Poser CM (1992): Multiple sclerosis. Observations and reflections - A personal memoir. J Neurol Sci 107:127-140.
73. Poser CM (1994): The role of trauma in the pathogenesis of multiple sclerosis: A review. Clin Neurol Neurosurg 96:103-110.
74. Prochazka M, Voltnerova M, Stefan J (1971): Studies of immunological reactions after brain injury. II. Antibodies against brain tissue lipids after blunt head injury in man. Int Surg 55(5):322-326.
75. Quattrocchi KB, Frank EH, Miller CH, MacDermott JPA, Hein L, Frey L, Wagner FC, Jr (1990): Suppression of cellular immune activity following severe head injury. J Neurotrauma 7:77-87.
76. Quattrocchi KB, Issel BW, Miller CH, Frank EH, Wagner FC, Jr (1992a): Impairment of helper T-cell function following severe head injury. J Neurotrauma 9:1-9.
77. Quattrocchi KB, Miller CH, Wagner FC, Jr, DeNardo SJ, DeNardo GL, Ovodov K, Frank EH, (1992b): Cell-mediated immunity in severely head-injured patients: The role of suppressor lymphocytes and serum factors. J Neurosurg 77:694-699.
78. Racke MK, Dhib-Jalbut S, Cannella B, Albert PS, Raine CS, McFarlin, DE (1991): Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-β1. J Immunol 146:3012-3017.
79. Raine CS (1984): Analysis of autoimmune demyelination: Its impact upon multiple sclerosis. Lab Invest 50(6):608-635.
80. + T-cells in vitro. J Immunol 156:2406-2412
81. Reier PJ, Anderson DK, Young W, Michel ME, Fessler R (1994): Workshop on intraspinal transplantation and clinical application. J Neurotrauma 11:369-377.
82. Rivers TM, Sprunt DH, Berry GP (1933): Observations on attempts to produce acute disseminated encephalomyelitis in monkeys. J Exp Med 58:39-53.
83. Rose NR, Bona C (1993): Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today 14:426-430.
84. Schwartz RH (1989): Acquisition of immunologic self-tolerance. Cell 57:1073-1081.
85. Sedgwick JD, Schwender S, Gregersen R, Dorries R, ter Meulen V (1993): Resident macrophages (ramified microglia) of the adult brown Norway rat central nervous system are constitutively major histocompatibility complex class II positive. J Exp Med 177:1145-1152.
86. Semple-Rowland SL, Mahatme A, Popovich PG, Green DA, Hassler G, Stokes BT, Streit WJ (1995): Analysis of TGF-β1 gene expression in contused rat spinal cord using quantitative RT-PCR. J Neurotrauma 12:1003-1014.
87. Shalit F, Sredni B, Brodie C, Kott E, Huberman M (1995): T lymphocyte subpopulations and activation markers correlate with severity of Alzheimer's disease. Clin Immunol Immunopathol 75:246-250.
88. Sharma HS, Olsson Y, Nyberg F, Dey PK (1993): Prostaglandins modulate alterations of microvascular permeability, blood flow, edema and serotonin levels following spinal cord injury: An experimental study in the rat. Neuroscience 57:443-449.
89. Simmons RD, Buzbee TM, Linthicum DS, Mandy WJ, Chen G, Wang C (1987): Simultaneous visualization of vascular permeability change and leukocyte egress in the central nervous system during autoimmune encephalomyelitis. Acta Neuropathol (Berlin) 74:191-193.
90. Singh VK, Yang YY, Singh EA (1992): Immunoblot detection of antibodies to myelin basic protein in Alzheimer's disease patients. Neurosci Lett 147:25-28.
91. Stefan J, Prochazka M, Voltnerova M (1971): Studies of immunologic reactions after brain injury. I. Antibodies against brain tissue lipids after experimental injury of the brain in rabbits. Int Surg 55(5):316-321.
92. Stokes BT, Noyes DH, Behrmann DL (1992): An electromechanical spinal injury device with dynamic sensitivity. J Neurotrauma 9:187-195.
93. Streit WJ, Graeber MB, Kreutzberg GW (1989a): Expression of la antigen on perivascular and microglial cells after sublethal and lethal motor neuron injury. Exp Neurol 105:115-126.
94. Streit WJ, Graeber MB, Kreutzberg GW (1989b): Peripheral nerve lesion produces increased levels of major histocompatibility complex antigens in the central nervous system. J Neuroimmunol 21:117-123.
95. Theofilopoulos AN (1995): The basis of autoimmunity: Part II. Genetic predisposition. Immunol Today 16:150-159.
96. Waxman SG (1992): Demyelination in spinal cord injury and multiple sclerosis: What can we do to enhance functional recovery. J Neurotrauma 9:S105-S117.
97. Whitacre CC, Gienapp IE, Orosz CG, Bitar DM (1991): Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence forclonal anergy. J Immunol 147:2155-2163.
98. Wilbanks GA, Streilein JW (1992): Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-beta. Eur J Immunol 22:1031-1036.
99. Willenborg DO, Staten EA, Eidelberg E (1977): Studies on cell-mediated hypersensitivity to neural antigens after experimental spinal cord injury. Exp Neurol 54:383-392.
100. Wood MJ, Byrnes AP, Pfaff DW, Rabkin SD, Chariten HM (1994): Inflammatory effects of gene transfer into the CNS with defective HSV-1 vectors. Gene Ther 1:283-291.
101. Woodroofe MN, Bellamy AS, Feldmann M, Davison AN, Cuzner ML (1986): Immunocytochemical characterisation of the immune reaction in the central nervous system in multiple sclerosis. Possible role for microglia in lesion growth. J Neurol Sci 74:135-152.
102. Yakovlev AG, Faden AI (1994): Sequential expression of c-fos protooncogene, TNF-α, and dynorphin genes in spinal cord following experimental traumatic. Mol Chem Neuropathol 23:179-190.
103. Yan HQ, Banos MA, Herregodts P, Hooghe R, Hooghe-Peters EL (1992): Expression of interleukin (IL)-l beta, IL-6 and their respective receptors in the normal rat brain and after injury. Eur J Immunol 22:2963-2971.
104. Yang Y, Li Q, Ertl HC, Wilson JM (1995): Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol 69:2004-2015.
105. Yarom Y, Naparstek Y, Lev-Ram V, Holoshitz J, Ben-Nun A, Cohen IR (1983): Immunospecific inhibition of nerve conduction by T lymphocytes. Nature 303:246-247.
106. Young W (1989): Recovery Mechanisms in Spinal Cord Injury: Implications for Regenerative Therapy. In Seil FJ (ed): "Neural Regeneration and Transplantation." New York: Alan R. Liss, pp 157-70.
107. Zamvil SS, Steinman L (1990): The T lymphocyte in experimental allergic encephalomyelitis. Annu Rev Immunol 8:579-621.